171 related articles for article (PubMed ID: 25577247)
1. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.
Sang W; Zhang W; Cui W; Li X; Abulajiang G; Li Q
Tumour Biol; 2015 May; 36(5):3881-6. PubMed ID: 25577247
[TBL] [Abstract][Full Text] [Related]
2. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
Atta IS
Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases.
Chen D; Li Z; Song Q; Qian L; Xie B; Zhu J
Medicine (Baltimore); 2018 Dec; 97(50):e13356. PubMed ID: 30557986
[TBL] [Abstract][Full Text] [Related]
6. α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.
Lu SX; Huang YH; Liu LL; Zhang CZ; Yang X; Yang YZ; Shao CK; Li JM; Xie D; Zhang X; Jain D; Yun JP
Br J Cancer; 2021 Jun; 124(12):1988-1996. PubMed ID: 33824478
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
[TBL] [Abstract][Full Text] [Related]
8. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
[TBL] [Abstract][Full Text] [Related]
9. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
[TBL] [Abstract][Full Text] [Related]
10. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
Timek DT; Shi J; Liu H; Lin F
Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
[TBL] [Abstract][Full Text] [Related]
11. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
Fatima N; Cohen C; Siddiqui MT
Acta Cytol; 2014; 58(1):83-8. PubMed ID: 24281232
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
13. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
McKnight R; Nassar A; Cohen C; Siddiqui MT
Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
Ibrahim TR; Abdel-Raouf SM
Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte paraffin 1 and arginase-1 are effective panel of markers in HBV-related HCC diagnosis in fine-needle aspiration specimens.
Moudi B; Mahmoudzadeh-Sagheb H; Heidari Z
BMC Res Notes; 2020 Aug; 13(1):388. PubMed ID: 32854754
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver.
Labib OH; Harb OA; Khalil OH; Baiomy TA; Gertallah LM; Ahmed RZ
J Gastrointest Cancer; 2020 Mar; 51(1):88-101. PubMed ID: 30784016
[TBL] [Abstract][Full Text] [Related]
17. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
[TBL] [Abstract][Full Text] [Related]
18. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
Fujiwara M; Kwok S; Yano H; Pai RK
Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
20. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]